Glooko Webinar: Optimize Diabetes Care
The Glooko 101 Webinar highlights digital platforms integrating data from devices, wearables, and manual input to streamline diabetes care [https://www.youtube.com/watch?v=3K5F6qKCUGI]. The webinar focuses on data aggregation, improved decision-making, and patient engagement through digital tools. What are the key pricing tiers for Glooko's platform?
Glooko was co-founded in 2010 by Yogen Dalal and Aneesh Asthana in Silicon Valley to address the challenge of fragmented diabetes data. Their initial product was an iOS app and a meter sync cable. The company's name reflects its focus on glucose data and management. Glooko's platform integrates with over 200 diabetes and health monitoring devices, fitness wearables, and activity trackers. The platform has amassed over 100 billion data points from 30 countries in 20 languages. This data is used to provide insights to both patients and clinicians. Glooko acquired Diasend in September 2016, expanding its global reach. In January 2022, Glooko acquired xbird, a German health machine-learning company. As of October 2024, Glooko has raised $201 million in funding over 8 rounds. Glooko's competitors include Twin Health, Livongo, DarioHealth, Omada Health, and Virta Health. Glooko's platform is used by more than 1 million people with diabetes and 7,000 health systems in 23 countries. Glooko offers a free mobile app for individuals. Mike Alvarez was appointed CEO of Glooko in October 2024. Glooko's platform is HIPAA, GDPR, ISO 13485, and 21 CFR Part 11 compliant. Glooko has partnered with companies like Abbott, Roche, Medtronic, and Samsung. Glooko's platform is used in clinical trials to capture real-world data. The platform provides insights into glucose data fluctuations based on lifestyle events, including exercise, food, carbs, and medications. The company provides remote patient monitoring (RPM) and has observed improvements in glycemic outcomes.
